RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSCritCare: Must-listen podcast for critical care. Insights from the leaders of the ROSE study, Derek Angus and Marc Moss, on when to…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
@SMHCoEMV @KariLynWhite @gaudio_dominic @Jleetoronto @PamelaGreco13
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
RT @ATSfellows: When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM artic…
When should I use neuromuscular blockade in moderate/ severe ARDS? Link podcast: https://t.co/GuTyI3DjuY Link @NEJM article: https://t.co/6WvWQlq59V We spoke with Drs Moss and Angus about their NEJM publication, and gained their insights about NMB and A
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/OKPV3YJ5Ws
Trial results on neuromuscular blockade in acute respiratory distress syndrome #ARDS in New England Journal of Medicine https://t.co/qqCIMLTRIR https://t.co/MNLztc4W5a
@BCDreyer In scientific prose where I am going to need to do a lot of counting, it gets awkward fast, as per your other examples: “213 patients (42.5%) in the intervention group and 216 (42.8%) in the control group had died before hospital discharge “ ht
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @CVCSCCM: T1C: Exclusion criteria: continuous NMB at enrollment, life expectancy < 24 hrs, severe chronic liver disease, chronic resp fa…
T1C: Exclusion criteria: continuous NMB at enrollment, life expectancy < 24 hrs, severe chronic liver disease, chronic resp failure and home vent use, weight > 1kg/cm of height and others, refer to supp index for a comprehensive list https://t.co/96w
You can view the study at https://t.co/96wQkUmvLu #cvcsccmjc
RT @VCCPharmD: Join us tonight for #CVCSCCMjc on the #ROSE trial https://t.co/AFvrVTsRnd
Join us tonight for #CVCSCCMjc on the #ROSE trial
Join us in discussing the #ROSE trial tomorrow from 8–9PM EST. Make sure to introduce yourself, share any conflicts of interest and don’t forget to use the hashtag #CVCSCCMjc. #visualabstract by @ansakhuja, #fulltext at @NEJM https://t.co/96wQkUE7a4 @Banda
Tomorrow night! I’m gonna try to chime in. Downloading article today to read in prep. Thanks for the visual abstract.
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
RT @AGMRRT: Great visual representation of the #Rose trial! @mlukej @SCCM @DukePulmFellows @Dr_Amy @DukePCCM @AlexRotta @skamath101 @donnat…
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
RT @AGMRRT: Great visual representation of the #Rose trial! @mlukej @SCCM @DukePulmFellows @Dr_Amy @DukePCCM @AlexRotta @skamath101 @donnat…
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
RT @AGMRRT: Great visual representation of the #Rose trial! @mlukej @SCCM @DukePulmFellows @Dr_Amy @DukePCCM @AlexRotta @skamath101 @donnat…
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
RT @CVCSCCM: The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exci…
Great visual representation of the #Rose trial! @mlukej @SCCM @DukePulmFellows @Dr_Amy @DukePCCM @AlexRotta @skamath101 @donnatanner815 @kdlamb1 @MadisonRRT @jcink17
The amazing visual abstract for the #ROSE trial by @ansakhuja-Remember to join us on Wed, July 17th from 8-9PM EST for an exciting discussion about the study at #CVCSCCMjc. @BandakGhassan Full text is available at https://t.co/96wQkUmvLu https://t.co/u1ubi
RT @WellingtonICU: This week's @WellingtonICU #Twitterjournalclub was prepared by @oweepower and is on the #ROSEtrial https://t.co/hHyS1vzK…
RT @abribriesco43: Thanks Nick (@ZimickMD) for asking about article for #RespiratoryICU @SCCM journal club. Below is the original tweet wi…
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
Thanks Nick (@ZimickMD) for asking about article for #RespiratoryICU @SCCM journal club. Below is the original tweet with @NEJM article @AGMRRT @donnatanner815 @kdlamb1 @MadisonRRT @julieajackson1 @CCF_PCCM
ROSE is a Rose is a Rose Great #ICUreadings conversation led by @mpirzad https://t.co/Mlx2Yk0xEK https://t.co/RpzHXu43h7
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/F2iJGY0R4U
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
RT @CVCSCCM: Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on…
Does early continuous neuromuscular blockade in #ARDS patients result in lower in-hospital mortality? Tune in to #CVCSCCMjc on July 17, 8-9 PM EST to discuss more about the latest study. Available at https://t.co/96wQkUE7a4 @BandakGhassan @SCCM #ROSE
RT @SapnaKmd: So one of our @JHPICUFellows gave a Sentinel Article review for journal club on the recently published ROSE Trial in @NEJM an…
#ICUreadings plan (1/2) @ColinRCooke will start us with T-Piece for SBT: https://t.co/orhFLEGeZK SPICE-3: https://t.co/Cgj1bbPB3t ROSE: https://t.co/Mlx2Yk0xEK PreVENT: https://t.co/hqOPIKT2pi ProveNET: https://t.co/NNQIB5YuPB
RT @CVCSCCM: Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM…
Just reviewed this article, I’ll try to join if I can! Learning about twitter journal clubs and they’re kind of fun!
RT @CVCSCCM: Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM…
RT @CVCSCCM: Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM…
RT @CVCSCCM: Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM…
RT @CVCSCCM: Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM…
Join us in discussing the role of early neuromuscular blockade in #ARDS patients at 8-9PM EST on July 17th in #CVCSCCMjc @NEJM article at https://t.co/96wQkUE7a4 @ansakhuja @SCCM #ROSE
So it can be summarized as "if you have NMB Agent indication, then you have prone indication.. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/wH1hrI1qGT
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/EPXOMUOqma
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @OregonSCCM: Last month, the ROSE study was published on early use of paralytic in #ARDS, and found no 90-day mortality benefit. Dr. Akr…
Last month, the ROSE study was published on early use of paralytic in #ARDS, and found no 90-day mortality benefit. Dr. Akram Khan from @OHSUPulmCCM was a contributing researcher. What do you think? How will this affect your practice? #criticalcare https
RT @AberdeenICUEdu: Journal Club Wed 8am: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome https://t.co/hZ4ZwcF276
Journal Club Wed 8am: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome https://t.co/hZ4ZwcF276
RT @AACNme: Early continuous #neuromuscular blockade for #patients with moderate-to-severe ARDS doesn't improve mortality compared to using…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…
RT @PulmCrit: guideline blooper: when your guideline has already been disproven... *before* it even reaches publication 🤣😂 ARDS guideline…